Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women.
Home Science Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy, study finds
Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy, study finds
